Innoviva (INVA) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.46% |
| Dec 31, 2025 | 15.62% |
| Sep 30, 2025 | 19.87% |
| Jun 30, 2025 | 24.58% |
| Mar 31, 2025 | 4.63% |
| Dec 31, 2024 | 17.01% |
| Sep 30, 2024 | 20.10% |
| Jun 30, 2024 | 21.67% |
| Mar 31, 2024 | -7.83% |
| Dec 31, 2023 | 7.51% |
| Sep 30, 2023 | 4.03% |
| Jun 30, 2023 | 20.12% |
| Mar 31, 2023 | -50.51% |
| Dec 31, 2022 | -3.24% |
| Sep 30, 2022 | 6.07% |
| Jun 30, 2022 | 30.80% |
| Mar 31, 2022 | 7.58% |
| Dec 31, 2021 | 49.15% |
| Sep 30, 2021 | 212.30% |
| Jun 30, 2021 | -84.71% |
| Mar 31, 2021 | 14.77% |
| Dec 31, 2020 | -48.56% |
| Sep 30, 2020 | 15.99% |
| Jun 30, 2020 | 17.38% |
| Mar 31, 2020 | 26.57% |
| Dec 31, 2019 | 60.80% |
| Sep 30, 2019 | 21.83% |
| Jun 30, 2019 | 117.88% |
| Mar 31, 2019 | 4.38% |
| Dec 31, 2018 | 28.39% |
| Sep 30, 2018 | -44.27% |
| Jun 30, 2018 | 221.42% |
| Mar 31, 2018 | -62.99% |
| Dec 31, 2017 | -47.02% |
| Sep 30, 2017 | 8.45% |
| Jun 30, 2017 | -20.13% |
| Mar 31, 2017 | 35.41% |
| Dec 31, 2016 | 26.63% |
| Sep 30, 2016 | -17.49% |
| Jun 30, 2016 | -25.59% |
| Mar 31, 2016 | -4.65% |
| Dec 31, 2015 | 102.14% |
| Sep 30, 2015 | -47.35% |
| Jun 30, 2015 | 5.94% |
| Mar 31, 2015 | 45.85% |
| Dec 31, 2014 | -19.05% |
| Sep 30, 2014 | -42.53% |
| Jun 30, 2014 | 66.08% |
| Mar 31, 2014 | -12.71% |
| Dec 31, 2013 | -16.51% |
| Sep 30, 2013 | -13.73% |
| Jun 30, 2013 | -25.12% |
| Mar 31, 2013 | 180.52% |
| Dec 31, 2012 | -15.49% |
| Sep 30, 2012 | -30.33% |
| Jun 30, 2012 | 1,025.76% |
| Mar 31, 2012 | -68.04% |
| Dec 31, 2011 | -28.62% |
| Sep 30, 2011 | -30.80% |
| Jun 30, 2011 | -38.69% |
| Mar 31, 2011 | -9.46% |
| Dec 31, 2010 | 158.84% |
| Sep 30, 2010 | -9.49% |